Cognitive behavioural therapy for obsessive-compulsive symptoms in schizophrenia

International Journal of Law in Context

Volumn 6, Issue 4, 2013, Pages

  Schirmbeck, Frederike ^a   Zink, Mathias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cognitive behavioural therapy; comorbidity; obsessive compulsive; schizophrenia

Indexed keywords

EID: 84912534834     PISSN: 17445523     EISSN: 17445531     Source Type: Journal    
DOI: 10.1017/S1754470X13000123     Document Type: Review

References (52)

1. Abramowitz JS, Franklin ME, Foa EB (2002). Empirical status of cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analytic review. Romanian Journal of Cognitive & Behavioral Psychotherapies 2, 89-104.
2. Achim AM, Maziade M, Raymond E, Olivier D, Merette C, Roy MA (2011). How prevalent are anxiety disorders in schizophrenia? a meta-analysis and critical review on a significant association. Schizophrenia Bulletin 37, 811-821.
3. Andrade C (2013). Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia. Journal of Clinical Psychiatry 73, 1362-1364.
4. Bauml J, Frobose T, Kraemer S, Rentrop M, Pitschel-Walz G (2006). Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families. Schizophrenia Bulletin 32 (Suppl. 1), 1-9.
5. Buckley PF, Miller BJ, Lehrer DS, Castle DJ (2009). Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin 35, 383-402.
6. Canas F, Aydinoglu U, Sinani G (2012). Valproic acid augmentation in clozapine-associated handwashing compulsion. Psychiatry and Clinical Neurosciences 66, 463-464.
7. Cunill R, Castells X, Simeon D (2009). Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. Journal of Clinical Psychiatry 70, 70-82.
8. de Haan L, Dudek-Hodge C, Verhoeven Y, Denys D (2009). Prevalence of psychotic disorders in patients with obsessive-compulsive disorder. CNS Spectrums 14, 415-417.
9. de Haan L, Hoogenboom B, Beuk N, van Amelsvoort T, Linszen D (2005). Obsessivecompulsive symptoms and positive, negative, and depressive symptoms in patients with recent-onset schizophrenic disorders. Canadian Journal of Psychiatry 50, 519-524.
10. de Haan L, Sterk B, van der Valk R (2012a). Presence of obsessive compulsive symptoms in first-episode schizophrenia or related disorders is associated with subjective well-being and quality of life. Early Intervention in Psychiatry. Published online: 2 July 2012. doi:10.1111/j.1751-7893.2012.00377.x.
11. de Haan L, Sterk B, Wouters L, Linszen DH (2012b). The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophrenia Bulletin 39, 151-160.
12. Ekers D, Carman S, Schlich T (2004). Successful outcome of exposure and response and prevention in the treatment of obsessive compulsive disorder in a patient with schizophrenia. Behavioural and Cognitive Psychotherapy 32, 375-378.
13. Faragian S, Pashinian A, Fuchs C, Poyurovsky M (2009). Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33, 1009-1012.
14. First MB, Spitzer RL, Gibbon M, Williams J (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version. New York: Biometrics Research.
15. Frueh BC, Cusack KJ, Grubaugh AL, Sauvageot JA, Wells C (2006). Clinicians' perspectives on cognitive-behavioral treatment for PTSD among persons with severe mental illness. Psychiatric Services 57, 1027-1031.
16. Gaebel W, Riesbeck M, Wobrock T (2011). Schizophrenia guidelines across the world: a selective review and comparison. International Review of Psychiatry 23, 379-387.
17. Ganesan V, Kumar TCR, Khanna S (2001). Obsessive-compulsive disorder and psychosis. Canadian Journal of Psychiatry 46, 750-754.
18. GoodmanWK, Price LH, Rasmussen SA, Mazure C (1989). The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry 46, 1006-1011.
19. Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT (2012). Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Archives of General Psychiatry 69, 121-127.
20. Hwang MY, Kim SW, Yum SY, Opler LA (2009). Management of schizophrenia with obsessivecompulsive features. Psychiatric Clinics of North America 32, 835-851.
21. Jaeger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuse I,Maier W, LemkeMR, Ruether E, Buckkremer G, Gastpar M, Riedel M, Bottlander R, Strauss A,Moeller H-J (2008). Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures. Pharmacopsychiatry 41, 190-195.
22. Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS (2008). Amisulpride improves obsessivecompulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study. Journal of Clinical Psychopharmacology 28, 349-352.
23. Kingdon DG, Turkington D (1994). Cognitive Therapy of Schizophrenia. New York: Guilford.
24. Kobori O, Sato H, Katsukura R, Harada S (2008). Cognitive behavioural therapy for obsessive compulsive symptoms affected by past psychotic experience of schizophrenia: a case report. Behavioural and Cognitive Psychotherapy 36, 365-369.
25. Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB, American Psychiatric Association (2007). Practice guideline for the treatment of patients with obsessive-compulsive disorder. American Journal of Psychiatry 164 (7 Suppl.), 5-53.
26. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J, American Psychiatric Association, Steering Committee on Practice Guidelines (2004). Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry 161 (2 Suppl.), 1-56.
27. Lincoln T (2006). Kognitive Verhaltenstherapie der Schizophrenie: Ein individuenzentrierter Ansatz zur Veraenderung von Wahn, Halluzinationen und Negativsymptomatik. Göttingen, Hogrefe.
28. Lysaker PH, Whitney KA (2009). Obsessive-compulsive symptoms in schizophrenia: prevalence, correlates and treatment. Expert Review of Neurotherapeutics 9, 99-107.
29. Lysaker PH, Whitney KA, Davis LW (2006). Obsessive-compulsive and negative symptoms in schizophrenia: associations with coping preference and hope. Psychiatry Research 141, 253-259.
30. MacCabe JH, Marks IM, Murray RM (2002). Behavior therapy attenuates clozapine-induced obsessions and compulsions. Journal of Clinical Psychiatry 63, 1179-1180.
31. Moritz S, Peters MJV, Laroi F, Lincoln TM (2010). Metacognitive beliefs in obsessive-compulsive patients: a comparison with healthy and schizophrenia participants. Cognitive Neuropsychiatry 15, 531-548.
32. Mukhopadhaya K, Krishnaiah R, Taye T, Nigam A, Bailey AJ, Sivakumaran T, Fineberg NA (2009). Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern. Journal of Psychopharmacology 23, 6-13.
33. Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J (2002). Treatment non-response in OCD: methodological issues and operational definitions. International Journal of Neuropsychopharmacology 5, 181-191.
34. Peasley-Miklus C, Massie E, Baslett G, Carmin C (2005). Treating obsessive-compulsive disorder and schizophrenia: the case of Sam. Cognitive and Behavioral Practice 12, 379-383.
35. Poyurovsky M, Glick I, Koran LM (2010). Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms. Journal of Psychopharmacology 24, 861-866.
36. Poyurovsky M, Koran LM (2005). Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. Journal of Psychiatric Research 39, 399-408.
37. Rodriguez CI, Corcoran C, Simpson HB (2010). Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms. American Journal of Psychiatry 167, 754-761.
38. Rosa-Alcazar AI, Sanchez-Meca J, Gomez-Conesa A, Marin-Martinez F (2008). Psychological treatment of obsessive-compulsive disorder: a meta-analysis. Clinical Psychology Review 28, 1310-1325.
39. Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, Fricke S, Peter H (2005). Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo. European Archives of Psychiatry and Clinical Neuroscience 255, 121-128.
40. Rufer M, Watzke B (2006). Ambulante Verhaltenstherapie mit intensiver Exposition einer Patientin mit Zwangsstörung und früherer Psychose. In: Verhaltenstherapie bei Zwangsstörungen: Fallbasierte Therapiekonzepte (ed. S. Fricke, M. Rufer and I. Hand), pp. 147-164. München: Elsevier.
41. Salkovskis PM (2007). Psychological treatment of obsessive-compulsive disorder. Psychiatry 6, 229-233.
42. Sarin F, Wallin L, Widerloev B (2011). Cognitive behavior therapy for schizophrenia: a metaanalytical review of randomized controlled trials. Nordic Journal of Psychiatry 65, 162-174.
43. Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M (2012a). Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study. Published online: 27 October 2012. Schizophrenia Bulletin. doi:10.1093/schbul/sbs123.
44. Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M (2012b). Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study. Journal of Psychopharmacology. Published online: 24 October 2012. doi:10.1177/0269881112463470.
45. Schirmbeck F, ZinkM(2012a). Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Current Neuropharmacology 10, 88-95.
46. Schirmbeck F, Zink M (2012b). Obsessive-compulsive syndromes in schizophrenia: a case for polypharmacy? In: Polypharmacy in Psychiatric Practice, 1st edn (ed. M. Ritsner), pp. 233-261. Dordrecht, Heidelberg, New York, London: Springer.
47. Stengel E (1945). A study on some clinical aspects of the relationship between obsessional neurosis and psychotic reaction types. Journal of Mental Science 91, 166-187.
48. Tundo A, Salvati L, Di Spigno D, Cieri L, Parena A, Necci R, Sciortino S (2012). Cognitivebehavioral therapy for obsessive-compulsive disorder as a comorbidity with schizophrenia or schizoaffective disorder. Psychotherapy and Psychosomatics 81, 58-60.
49. Veale D (2007). Cognitive-behavioural therapy for obsessive-compulsive disorder. Advances in Psychiatric Treatment 13, 438-446.
50. Westphal K (1878). About obsessions. Archiv für Psychiatrie und Nervenkrankheiten 8, 734-750.
51. Wykes T, Steel C, Everitt B, Tarrier N (2008). Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 34, 523-537.
52. Zink M, Englisch S, Knopf U, Kuwilsky A, Dressing H (2007). Augmentation of clozapine with valproic acid for clozapine-induced obsessive compulsive symptoms. Pharmacopsychiatry 40, 202-203.